Publication:
In vivo evaluation of a recombinant N-acylhomoserine lactonase formulated in a hydrogel using a murine model infected with MDR Pseudomonas aeruginosa clinical isolate, CCASUP2

Simple item page
dc.contributor.authorSakr, Masarra M.
dc.contributor.authorAboshanab, Khaled M.
dc.contributor.authorMantawy, Eman M.
dc.contributor.authorYassien, Mahmoud A.
dc.contributor.authorHassouna, Nadia A.
dc.contributor.authorElkhatib, Walid F.
dc.date.accessioned2023-02-02T11:09:03Z
dc.date.available2023-02-02T11:09:03Z
dc.date.issued2021-07-27
dc.description.abstractFailure in the treatment of P. aeruginosa, due to its broad spectrum of resistance, has been associated with increased patient mortality. One alternative approach for infection control is quorum quenching which was found to decrease virulence of such pathogen. In this study, the efficiency of a recombinant Ahl-1 lactonase formulated as a hydrogel was investigated to control the infection of multidrug resistant (MDR) P. aeruginosa infected burn using a murine model. The recombinant N-acylhomoserine lactonase (Ahl-1) was formulated as a hydrogel. To test its ability to control the infection of MDR P. aeruginosa, a thermal injury model was used. Survival rate, and systemic spread of the infection were evaluated. Histopathological examination of the animal dorsal skin was also done for monitoring the healing and cellular changes at the site of infection. Survival rate in the treated group was 100% relative to 40% in the control group. A decrease of up to 3 logs of bacterial count in the blood samples of the treated animals relative to the control group and a decrease of up to 4 logs and 2.3 logs of bacteria in lung and liver samples, respectively were observed. Histopathological examination revealed more enhanced healing process in the treated group. Accordingly, by promoting healing of infected MDR P. aeruginosa burn and by reducing systemic spread of the infection as well as decreasing mortality rate, Ahl-1 hydrogel application is a promising strategy that can be used to combat and control P. aeruginosa burn infections.
dc.identifier.citationSakr, M.M., Elkhatib, W.F., Aboshanab, K.M. et al. In vivo evaluation of a recombinant N-acylhomoserine lactonase formulated in a hydrogel using a murine model infected with MDR Pseudomonas aeruginosa clinical isolate, CCASUP2. AMB Expr 11, 109 (2021). https://doi.org/10.1186/s13568-021-01269-7
dc.identifier.doi10.1186/s13568-021-01269-7
dc.identifier.issn2191-0855
dc.identifier.pages10
dc.identifier.urihttps://research.gu.edu.eg/handle/123456789/308
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofAMB Express
dc.source.urihttps://amb-express.springeropen.com/articles/10.1186/s13568-021-01269-7
dc.subjectP. aeruginosa
dc.subjectN-acylhomoserine lactonase
dc.subjectBurn infection
dc.subjectQuorum quenching
dc.titleIn vivo evaluation of a recombinant N-acylhomoserine lactonase formulated in a hydrogel using a murine model infected with MDR Pseudomonas aeruginosa clinical isolate, CCASUP2
dc.typeArticle
dspace.entity.typePublication
oaire.citation.issue1
oaire.citation.volume11
relation.isAuthorOfPublication92797dd3-4a77-4ef2-b20d-bc2e3a26d692
relation.isAuthorOfPublication.latestForDiscovery92797dd3-4a77-4ef2-b20d-bc2e3a26d692
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
In vivo evaluation of a recombinant.pdf
Size:
1.61 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Articles